Stock Update (NYSE:LLY): U.S. FDA approves Eli Lilly drug for stomach cancer

[Reuters] – U.S. health regulators on Monday approved an Eli Lilly and Co drug to treat advanced stomach cancer and a form of cancer in the area where the esophagus joins the stomach. . . . → Read More: Stock Update (NYSE:LLY): U.S. FDA approves Eli Lilly drug for stomach cancer Similar Articles: Celgene Corporation (NASDAQ:CELG) – U.S. FDA approves Celgene drug for psoriatic arthritis Company Update: Pfizer Inc (NYSE:PFE) – Pfizer’s new breast cancer drug succeeds in trial Merck & Co Inc (NYSE:MRK) | Merck hits a new high as analyst sees opening for new cancer drug